The Indian equity market declined this week, with the Nifty falling 0.7% to close a three-session winning streak. The decline was driven by weakness in banking stocks after a recent rally and concerns about inflation remaining high after a services PMI index slipped to a five-month low, suggesting continued economic pressures. Top gainers for the week included Ranbaxy, JP Associates, and BHEL, while top losers were HUL, Airtel, and Sun Pharma.

1. Weekly Equity Report (09 APR 2012)
Weekly News Hitting Indian Market
 Sensex, Nifty hit; services PMI revives worries.
 Eurozone composite PMI confirms contraction.
 Another Fed stimulus less likely: FOMC minutes.
 India's services PMI slides in March.
 IMD sees monsoon ‘above normal’ in 2012.
Weekly trend of the Market
The Nifty headed for their first fall in four sessions after a services index slipped to a five-month low,
raising some concerns about the economy and leading investors to book profits in banking stocks after the
recent rally in the sector.
The HSBC Market Business Activity index fell to 52.3 in March from 56.5 the previous month. Although
that was above the 50 level that indicates expansion, the extent of the fall worried some investors.
The same indicator showed input prices charged to consumers inched up in March, suggesting inflation
could remain high, which would dampen the prospect of an interest rate cut at the central bank meeting
on April 17.
"While the service sector is still expanding and showing some degree of resilience, the lingering inflation
pressures and lack of economic policy progress is dampening sentiments and growth," HSBC said in a note
to clients on Wednesday.
The NSE Bank Nifty fell 1.2%, after gaining 5.1% over the previous three sessions. The broader Nifty fell
0.7%, ending a three-session winning streak.

2. www.epicresearch.co+919993959693
Weekly Nifty Gainers
COMPANY CURR.RATE VOL PREV.CL CHANGE NET CHG
Ranbaxy 477.95 792.92 419.50 58.45 13.93
JP Asso 86.00 17812.27 76.95 9.05 11.76
BHEL 273.60 3822.71 252.15 21.45 8.51
HCL Tech. 509.05 630.27 470.60 38.45 8.17
IDFC 138.80 6226.02 128.85 9.95 7.72
Weekly Nifty Losers
COMPANY CURR.RATE VOL PREV.CL CHANGE NET CHG
HUL 399.20 1830.51 412.50 -13.30 -3.22
Airtel 330.10 3172.26 337.75 -7.65 -2.26
Sun Pharma 564.10 464.12 568.05 -3.95 -0.70
Bajaj Auto 1633.45 216.60 1637.80 -4.35 -0.27
JSPL 524.70 1692.48 526.00 -1.30 -0.25
Weekly Nifty pivots
Pivot R4 R3 R2 R1 PP S1 S2 S3 S4
Nifty 5626 5526 5426 5374 5326 5274 5226 5126 5026
www.epicresearch.co +919993959693

3. www.epicresearch.co+919993959693
Weekly Nifty chart
Weekly BANK Nifty chart
www.epicresearch.co +919993959693

4. www.epicresearch.co+919993959693
Disclaimer
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not
accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits
them the most.
Sincere efforts have been made to present the right investment perspective. The information contained herein is based on
analysis and up on sources that we consider reliable.
This material is for personal information and based upon it & takes no responsibility
The information given herein should be treated as only factor, while making investment decision. The report does not
provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate
particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall
not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules
and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price performance. The information herein,
together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be
holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at
his free will and does not read any views expressed as a recommendation for which either the site or its owners or
anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer.
All Rights Reserved.
Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred
whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not
purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or
anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone
which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.
www.epicresearch.co +919993959693